[PDF][PDF] Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
…, D Chaterjee, S Ding, WD Tolbert, MW Grunst, Y Bo… - Cell reports, 2022 - cell.com
Emerging variants of concern for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
can transmit more efficiently and partially evade protective immune responses, …
can transmit more efficiently and partially evade protective immune responses, …
[PDF][PDF] Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
…, G Gendron-Lepage, H Medjahed, G Goyette, Y Bo… - Cell host & …, 2022 - cell.com
The standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two doses
administered three weeks apart. However, some public health authorities spaced these …
administered three weeks apart. However, some public health authorities spaced these …
[HTML][HTML] Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
…, J Richard, J Prévost, A Tauzin, R Gasser, Y Bo… - Virology, 2021 - Elsevier
Towards the end of 2020, multiple variants of concern (VOCs) and variants of interest (VOIs)
have arisen from the original SARS-CoV-2 Wuhan-Hu-1 strain. Mutations in the Spike …
have arisen from the original SARS-CoV-2 Wuhan-Hu-1 strain. Mutations in the Spike …
[PDF][PDF] SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
…, M Boutin, C Bourassa, G Beaudoin-Bussières, Y Bo… - Cell reports, 2022 - cell.com
Continuous emergence of SARS-CoV-2 variants of concern (VOCs) is fueling the COVID-19
pandemic. Omicron (B.1.1.529) rapidly spread worldwide. The large number of mutations in …
pandemic. Omicron (B.1.1.529) rapidly spread worldwide. The large number of mutations in …
[PDF][PDF] Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
…, K Dionne, SY Gong, G Gendron-Lepage, Y Bo… - Cell Reports, 2023 - cell.com
Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants
have recently emerged, becoming the dominant circulating strains in many countries. …
have recently emerged, becoming the dominant circulating strains in many countries. …
[PDF][PDF] A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
…, H Medjahed, G Goyette, JC Williams, Y Bo… - Cell reports, 2022 - cell.com
Due to the recrudescence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections worldwide, mainly caused by the Omicron variant of concern (VOC) and its sub-…
infections worldwide, mainly caused by the Omicron variant of concern (VOC) and its sub-…
[PDF][PDF] Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron
…, J Prévost, G Beaudoin-Bussières, R Daniel, Y Bo… - IScience, 2022 - cell.com
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike glycoprotein (S)
binds to angiotensin-converting enzyme 2 (ACE2) to mediate membrane fusion via two …
binds to angiotensin-converting enzyme 2 (ACE2) to mediate membrane fusion via two …
[HTML][HTML] A recent SARS-CoV-2 infection enhances antibody-dependent cellular cytotoxicity against Several Omicron subvariants following a fourth mRNA vaccine …
…, H Medjahed, J Perreault, I Levade, L Alfadhli, Y Bo… - Viruses, 2023 - mdpi.com
Since the beginning of the SARS-CoV-2 pandemic, several variants of concern (VOCs), such
as the Alpha, Beta, Gamma, Delta and Omicron variants, have arisen and spread worldwide…
as the Alpha, Beta, Gamma, Delta and Omicron variants, have arisen and spread worldwide…
[HTML][HTML] Ebola virus requires phosphatidylinositol (3, 5) bisphosphate production for efficient viral entry
S Qiu, A Leung, Y Bo, RA Kozak, SP Anand… - Virology, 2018 - Elsevier
For entry, Ebola virus (EBOV) requires the interaction of its viral glycoprotein with the cellular
protein Niemann-Pick C1 (NPC1) which resides in late endosomes and lysosomes. How …
protein Niemann-Pick C1 (NPC1) which resides in late endosomes and lysosomes. How …
[HTML][HTML] Antigenicity of the Mu (B. 1.621) and A. 2.5 SARS-CoV-2 spikes
D Chatterjee, A Tauzin, A Laumaea, SY Gong, Y Bo… - Viruses, 2022 - mdpi.com
The rapid emergence of SARS-CoV-2 variants is fueling the recent waves of the COVID-19
pandemic. Here, we assessed ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 …
pandemic. Here, we assessed ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 …